These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21261737)

  • 21. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis.
    Tanaka N; Horiuchi A; Yokoyama T; Kawa S; Kiyosawa K
    Am J Gastroenterol; 2008 Jan; 103(1):245-6. PubMed ID: 18184133
    [No Abstract]   [Full Text] [Related]  

  • 22. Magnetic resonance imaging and computed tomography scan for the diagnosis of acute fatty liver of pregnancy.
    Farine D; Newhouse J; Owen J; Fox HE
    Am J Perinatol; 1990 Oct; 7(4):316-8. PubMed ID: 2152326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
    Goldhaber SZ
    Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
    McCaig FM; Renshaw L; Williams L; Young O; Murray J; Macaskill EJ; McHugh M; Hannon R; Dixon JM
    Breast Cancer Res Treat; 2010 Feb; 119(3):643-51. PubMed ID: 19941160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
    Runowicz CD
    Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    Fabian CJ; Kimler BF
    J Clin Oncol; 2005 Mar; 23(8):1644-55. PubMed ID: 15755972
    [No Abstract]   [Full Text] [Related]  

  • 27. Education and Imaging. Hepatobiliary and Pancreatic: Focal fatty infiltration of the liver mimicking malignancy in high-risk patients.
    Yalamanchi V; Wang W; Bunim A
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1228. PubMed ID: 26201669
    [No Abstract]   [Full Text] [Related]  

  • 28. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K; Goss PE
    J Clin Oncol; 2005 Mar; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen].
    Taniya T; Noguchi M; Tajiri K; Nakano Y; Kitabayashi K; Miyazaki I; Koshino Y; Nonomura A; Mabuchi H
    Gan No Rinsho; 1987 Mar; 33(3):300-4. PubMed ID: 3108557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [SERM--selective estrogen receptor modulators].
    Kønig KB; Eiken PA; Schwarz P
    Ugeskr Laeger; 2001 Apr; 163(15):2129-33. PubMed ID: 11332210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
    Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive and non-invasive investigations for tamoxifen-induced non-alcoholic steatohepatitis (NASH): the benefit of computed tomography scan guided liver biopsy.
    Ahmed MH; Osman KA; Osman MM
    Pathology; 2006 Jun; 38(3):270-1. PubMed ID: 16753757
    [No Abstract]   [Full Text] [Related]  

  • 35. Tamoxifen-induced radiation recall dermatitis.
    Singer EA; Warren RD; Pennanen MF; Collins BT; Hayes DF
    Breast J; 2004; 10(2):170-1. PubMed ID: 15009054
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.
    Castellon SA; Silverman DH; Ganz PA
    Breast Cancer Res Treat; 2005 Aug; 92(3):199-206. PubMed ID: 16155790
    [No Abstract]   [Full Text] [Related]  

  • 37. Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.
    Cohen I
    Fertil Steril; 2011 Sep; 96(3):e147; author reply e148. PubMed ID: 21762898
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence and Risk Factors of Tamoxifen Retinopathy.
    Kim HA; Lee S; Eah KS; Yoon YH
    Ophthalmology; 2020 Apr; 127(4):555-557. PubMed ID: 31813590
    [No Abstract]   [Full Text] [Related]  

  • 39. Benign hepatic cyst in a patient on antiestrogen therapy for metastatic breast cancer.
    Nand S; Gordon LI; Brestan E; Harris C; Brandt T
    Cancer; 1982 Nov; 50(9):1882-3. PubMed ID: 7116312
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen-induced steatohepatitis.
    Van Hoof M; Rahier J; Horsmans Y
    Ann Intern Med; 1996 May; 124(9):855-6. PubMed ID: 8610959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.